1. Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments
   Elena Gianchecchi et al, 2021, IJMS CrossRef
2. Long Intergenic Non-Coding RNAs in HNSCC: From “Junk DNA” to Important Prognostic Factor
   Joanna Kozłowska et al, 2021, Cancers CrossRef
3. Sialic Acid—Modified Nanoparticles—New Approaches in the Glioma Management—Perspective Review
   Przemyslaw Wielgat et al, 2021, IJMS CrossRef
4. Siglec-7 Mediates Immunomodulation by Colorectal Cancer-Associated Fusobacterium nucleatum ssp. animalis
   Dimitra Lamprinaki et al, 2021, Front. Immunol. CrossRef
5. Siglecs as Therapeutic Targets in Cancer
   Jackwee Lim et al, 2021, Biology CrossRef
6. Transgenic mouse models to study the physiological and pathophysiological roles of human Siglecs
   Kelli A. McCord et al, 2022 CrossRef
7. Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients
   Shayista Akbar et al, 2023, Front. Immunol. CrossRef
8. Tumor cell-intrinsic and tumor microenvironmental conditions co-determine signaling by the glycoimmune checkpoint receptor Siglec-7
   Eline J. H. van Houtum et al, 2023, Cell. Mol. Life Sci. CrossRef
9. High serum proteinase-3 levels predict poor progression-free survival and lower efficacy of bevacizumab in metastatic colorectal cancer
   Kei Furuya et al, 2024, BMC Cancer CrossRef
10. null
    Mohammed Saqif Ahmad et al, 2024 CrossRef